GlassScriptPhysician profile
Nader Zeitouni
NPI 1144273616
$18,024.97
in general payments reported to CMS, 2019-2025
58 companies · $3,339 in 2025
The $3,339 reported for 2025 was more than what 84% of Pulmonary Disease providers received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,469 · 2020: $1,325 · 2021: $2,130 · 2022: $2,627 · 2023: $2,880 · 2024: $3,254 · 2025: $3,339.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $8,986 · Education: $487.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $8,985.99 |
| Education | $487.03 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $2,128.60 | 2019-2025 | Trelegy Ellipta, Nucala, Arexvy |
| Astrazeneca Pharmaceuticals LP | $2,008.73 | 2019-2025 | Airsupra, Fasenra, Tezspire |
| Boehringer Ingelheim Pharmaceuticals, INC. | $1,255.46 | 2019-2025 | Ofev, Stiolto Respimat, Spiriva Respimat |
| Axsome Therapeutics, INC. | $1,099.45 | 2022-2025 | Sunosi |
| Harmony Biosciences LLC | $960.90 | 2020-2025 | Wakix |
| United Therapeutics Corporation | $927.13 | 2019-2025 | Tyvaso, Tyvaso, Orenitram |
| Baxter Healthcare | $862.16 | 2022-2025 | Hillrom - Vest System Model 105 Home Care, Hillrom - Life 2000 Ventilation System |
| Genzyme Corporation | $837.94 | 2019-2025 | |
| Jazz Pharmaceuticals INC. | $772.11 | 2019-2025 | |
| Grifols USA, LLC | $746.41 | 2019-2025 | Prolastin-C Liquid |
| Mylan Specialty L.P. | $685.51 | 2019-2024 | Yupelri |
| Takeda Pharmaceuticals U.S.A., INC. | $664.13 | 2020-2025 | Glassia |
| Amgen INC. | $574.54 | 2021-2025 | Tezspire, Evenity, Tavneos |
| Regeneron Healthcare Solutions, INC. | $514.58 | 2019-2025 | Dupixent |
| Actelion Pharmaceuticals US, INC. | $287.67 | 2019-2024 | Opsumit, Uptravi |
Show all 58 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Electromed, INC. | $258.76 | 2019-2025 | Smartvest |
| Insmed, INC. | $245.59 | 2020-2025 | Arikayce, Brinsupri |
| Avadel Cns Pharmaceuticals, LLC | $225.45 | 2024-2025 | Lumryz |
| Sanofi-Aventis U.S. LLC | $188.99 | 2022-2023 | |
| Janssen Pharmaceuticals, INC | $186.21 | 2019-2022 | |
| Merck Sharp & Dohme LLC | $162.15 | 2019-2023 | |
| Advanced Respiratory, INC | $161.72 | 2019-2021 | |
| Boston Scientific Corporation | $149.51 | 2022 | |
| Mallinckrodt Hospital Products INC. | $148.81 | 2021 | |
| Circassia INC. | $119.83 | 2019 | |
| Pfizer INC. | $118.55 | 2019-2025 | |
| Allergan, INC. | $117.61 | 2019 | |
| Inari Medical, INC. | $116.78 | 2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Dexcom, INC. | $110.33 | 2024 | Dexcom G6 Transmitter |
| Amarin Pharma, INC. | $110.00 | 2019 | |
| Viatris Specialty LLC | $99.99 | 2025 | Yupelri |
| Inogen, INC. | $93.69 | 2022-2025 | Inogen |
| Genentech USA, INC. | $90.49 | 2019-2023 | Esbriet, Xolair |
| Si-Bone, INC. | $88.80 | 2024 | |
| Philips North America LLC | $80.16 | 2019-2023 | |
| Abbvie INC. | $66.13 | 2023 | Vraylar |
| E.R. Squibb & Sons, L.L.C. | $57.01 | 2021-2023 | Eliquis |
| Lifenet Health | $55.55 | 2025 | Pliafx Flo, Allograft Vmis Delivery System |
| Depuy Synthes Sales INC. | $54.03 | 2025 | |
| Novartis Pharmaceuticals Corporation | $53.52 | 2019-2023 | |
| Paratek Pharmaceuticals, INC. | $51.61 | 2021 | |
| Verona Pharma, INC. | $49.07 | 2025 | Ohtuvayre |
| Tetraphase Pharmaceuticals, INC. | $47.79 | 2019-2020 | |
| Resmed Corp | $46.47 | 2019 | |
| Pulmonx Corporation | $36.51 | 2021 | |
| Eisai INC. | $36.20 | 2020 | |
| Astellas Pharma US INC | $33.20 | 2019-2021 | |
| Shire North American Group INC | $32.69 | 2019 | |
| Idorsia Pharmaceuticals US INC | $32.66 | 2022-2023 | Quviviq |
| Teva Pharmaceuticals USA, INC. | $26.31 | 2021-2022 | |
| Inspire Medical Systems, INC. | $23.53 | 2025 | Inspire |
| Mallinckrodt Enterprises LLC | $23.35 | 2019 | |
| Ani Pharmaceuticals, INC. | $21.93 | 2024 | Purified Cortrophin Gel |
| Arbor Pharmaceuticals, INC. | $18.91 | 2021 | |
| Mayne Pharma Commercial LLC | $17.54 | 2022 | |
| Fisher & Paykel Healthcare INC | $15.69 | 2019 | |
| Lilly USA, LLC | $14.30 | 2025 | Zepbound |
| Covis Pharma Gmbh | $12.23 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nader Zeitouni listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.